Avantor, Inc. (AVTR): Total Liabilities
$6.23B
As of 2025-12-31
$6.07B
As of 2026-03-31
-10.2%
3-year compound annual growth
-2.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.23B | +1.2% | 2026-02-11, Balance as of period end |
| 2024-12-31 | $6.16B | -20.2% | 2026-02-11, Balance as of period end |
| 2023-12-31 | $7.72B | -10.3% | 2025-02-07, Balance as of period end |
| 2022-12-31 | $8.61B | -11.3% | 2024-02-14, Balance as of period end |
| 2021-12-31 | $9.70B | +34.1% | 2023-02-14, Balance as of period end |
| 2020-12-31 | $7.23B | -1.1% | 2022-02-11, Balance as of period end |
| 2019-12-31 | $7.31B | -19.7% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $9.10B | n/a | 2020-02-14, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Avantor, Inc. (AVTR) | 2025-12-31 | $6.23B | +1.2% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $5.99B | +0.6% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $3.74B | +11.0% |
| Bruker Corp (BRKR) | 2025-12-31 | $3.73B | -6.5% |
| Waters Corp (WAT) | 2025-12-31 | $2.52B | -7.7% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $4.92B | +4.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $3.12B | +11.7% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $245.04M | +17.5% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $119.80M | +15.5% |
Compare AVTR, A, MTD, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗